Panel Discussion: Beyond the Microscope: Navigating the Future of Digital Pathology & Computational Biomarkers

• Explore the development and strategic rationale behind the TROP2 NMR computational biomarker
• Discuss how digital pathology and AI can solve large, looming questions in pathology
• Address the key barriers to computational pathology adoption, successful commercialisation and market enablement

Speakers:

Ross Hill

Scientific Lead - Global Oncology Diagnostics

AstraZeneca

Mark Hellewell

International Product Manager, PHCS Oncology

Roche

Michael Senior

Senior Director, Diagnostic Partnerships, Oncology Business Unit

AstraZeneca

Marilou Taggart

Senior Director, Global Commercial Diagnostics, Lung Franchises

AstraZeneca

John McAuliffe

Senior Director, PHCS Partnering 

Roche

Landon Inge

Global Medical Affairs

Roche